Grants8 | The most comprehensive grants search on the web

Grant Analysis

Purpose & Target

This grant aims to provide critical administrative and technical support for the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). The core objective is to ensure GloPID-R's dynamic and efficient functioning, enabling a rapid and effective research response to pandemics and severe epidemics globally. - Target recipient type: Organizations capable of providing secretariat functions for international scientific collaborations, typically research institutions, public bodies, or specialized non-governmental organizations. - Target size: Not specified, but implied to be organizations with significant capacity and experience. - SECTOR-SPECIFIC: Health and Research. - Geographic scope: Applicants must be from EU Member States, Associated Countries, or exceptionally US (for NIH-affiliated entities), to support a global collaboration (GloPID-R). - Key filtering criteria: Capacity to manage complex international scientific secretariat, expertise in infectious disease preparedness. - Grant frequency: This is a specific topic within the Horizon Europe 2025 Health call, part of an ongoing program (Horizon Europe 2021-2027).

Financial Structure

Funding mechanism: Lump sum contribution.
Budget range: The grant amount for this topic is a fixed lump sum of EUR 2,000,000.
Eligible costs: Covered by the lump sum, based on estimated direct and indirect project costs. Includes personnel costs (employees, seconded persons, SME owners, natural persons), subcontracting costs, purchase costs (travel, equipment, other goods/services), and other cost categories (financial support to third parties, internally invoiced goods/services, transnational/virtual access to research infrastructure).
Ineligible costs: Costs that would be considered ineligible under standard Horizon Europe rules should not be included in the lump sum calculation.
Matching fund/Co-financing: The total estimated costs of the action must be greater than the estimated Union contribution to comply with the co-financing principle.
Indirect cost policy: A flat rate of 25% is applied to the direct cost categories that qualify for indirect costs calculation under Horizon Europe rules.
Payment schedule: Payments are made upon proper implementation of the corresponding work packages, as defined in the grant agreement. Pre-financing follows standard Horizon Europe rules.
Financial reporting: No report of actual costs is required. Financial checks and audits are replaced by technical checks, reviews, or audits focused on the completion of work packages.
Financial guarantees: 5-8% of the total lump sum is retained as a contribution to the Mutual Insurance Mechanism.

Eligibility Requirements

Organizational Type and Location

Legal entities established in an EU Member State or Associated Country are eligible to coordinate and participate.
Legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding, specifically in recognition of the opening of the US National Institutes of Health's programs to European researchers.
Coordinators of projects must be legal entities established in an EU Member State or Associated Country.

Organizational Capacity and Experience

Proposals should demonstrate capability to provide administrative and technical support to maintain and support GloPID-R's continuous evolution.
Experience in research preparedness and response to infectious disease outbreaks is required for scientific advisors and working groups facilitation.

Exclusion Criteria

Entities assessed as 'high-risk suppliers' of mobile network communication equipment (and any entities they own or control) are not eligible to participate as beneficiaries, affiliated entities, and associated partners if the topic is identified as 'subject to restrictions for the protection of European communication networks'. This specific topic (HORIZON-HLTH-2025-01-DISEASE-05) is not identified as subject to such restrictions in the provided metadata, but this is a general condition to be aware of within the program context.

Application Process

Application Deadlines and Submission

Application deadline: 2025-09-16.
Submission session available from: 2025-05-22.
Submission procedure: Single-stage.
Submission platform: Applications must be submitted through the Funding & Tenders Portal's Electronic Submission Service.

Required Documentation and Materials

Standard application form (HE CSA) for Coordination and Support Actions.
Detailed budget table (HE LS) specifically for lump sum grants, showing breakdown per work package and per beneficiary/affiliated entity.
Adherence to proposal page limits and layout as described in Part B of the Application Form.

Evaluation Process and Timeline

Evaluation by external independent experts.
Indicative timeline for evaluation and grant agreement is described in Annex F of the Work Programme General Annexes (not specified in detail for this topic).

Support and Guidance

Online Manual: Comprehensive guide on procedures.
Funding & Tenders Portal FAQ: Answers to common questions.
HE Programme Guide: Detailed guidance on Horizon Europe structure and priorities.
National Contact Points (NCPs): Guidance and assistance on participation.
Enterprise Europe Network (EEN): Advice for businesses, especially SMEs.
IT Helpdesk: For technical issues with the submission portal.
European IPR Helpdesk: Assistance on intellectual property issues.
CEN-CENELEC Research Helpdesk and ETSI Research Helpdesk: Advice on standardisation in proposals.
European Charter for Researchers and Code of Conduct for their recruitment: General principles for researchers, employers, and funders.
Partner Search: Tools to find partner organizations.

Evaluation Criteria

Proposals will be evaluated based on the following criteria and thresholds: Excellence

Threshold: 4 (out of 5, typically)
Assessment of the quality of the proposal's objectives, methodology, and scientific soundness.

Impact

Threshold: 4 (out of 5, typically)
Assessment of the potential societal, economic, and environmental benefits of the proposed activities.
Contribution to the expected impacts of Destination 'Tackling diseases and reducing disease burden', including reduced disease burden, strengthened R&I expertise, reduced cross-border health threats, and empowered citizens.

Quality and Efficiency of the Implementation

Threshold: 4 (out of 5, typically)
Assessment of the quality and efficiency of the work plan, including the allocation of resources, management structure, and risk mitigation measures.

Overall Scoring

Cumulative threshold: 12 (sum of the scores for Excellence, Impact, and Implementation).

Budget Evaluation

Experts with financial know-how will check the budget estimate based on relevant benchmarks (market prices, statistical data, historical data).
Verification that resources proposed and the split of lump sum shares allow for achieving the activities and expected outputs.
Proposals must include a declaration that beneficiaries have followed their own accounting practices for budget preparation.
The estimated eligible costs must be broken down by budget category (personnel, subcontracting, purchase, other, indirect costs).

Compliance & Special Requirements

Compliance Requirements

Regulatory Compliance: Adherence to general Horizon Europe rules and the EU Financial Regulation (Regulation (EU, Euratom) No 2018/1046).
Ethical Standards: Compliance with ethical standards is an explicit focus of monitoring and evaluation.
Data Protection and Privacy: General EU regulations apply, though not specifically detailed for this grant.
Environmental Compliance: Not specifically detailed for this grant.
Labor Standards: Not specifically detailed for this grant.
Reporting Compliance: Focus on technical implementation and delivery of work packages; no financial cost reporting required due to lump sum model.

Special Considerations

Lump Sum Funding: This grant uses a lump sum model, which means payments are contingent upon the successful completion of work packages, rather than based on actual incurred costs. This simplifies financial management but places a strong emphasis on upfront budget planning and clear technical objectives.
Focus on Technical Implementation: Checks, reviews, and audits will primarily focus on the technical implementation of the action, including the fulfillment of conditions for releasing lump sum contributions, and compliance with ethics, research integrity, dissemination, exploitation, IP management, and gender equality.
Strategic Alignment: Projects should align with Horizon Europe's Key Strategic Orientation 3 ('A more resilient, competitive, inclusive, and democratic Europe') and contribute to the Health Cluster's impact goals related to tackling diseases and reducing disease burden.
Cross-cutting Priorities: The topic is identified with 'AI' and 'DigitalAgenda' as cross-cutting priorities, implying potential for digital tools in supporting GloPID-R's functions.
Adaptability: A high level of adaptability is expected to respond to rapidly evolving situations, particularly relevant for infectious disease preparedness.

Grant Details